Monday, August 2, 2010

Vol. 16, No. 15

TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 16, No. 15  August 2, 2010
(The next issue will be on August 16, 2010)
__________________________________________________________
TRIGGER is also available by RSS Feed:
http://feeds.feedburner.com/blogspot/glro
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None submitted for this issue.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1VEu7PlDIIjS77-P9GTNgy9/

Apostolopoulos J, Moussa L, and Tipping PG (2010) The cytoplasmic domain of tissue factor restricts physiological albuminuria and pathological proteinuria associated with glomerulonephritis in mice. Nephron Exp Nephrol 116:e72-e83
http://www.ncbi.nlm.nih.gov/pubmed/20664298

Ayer JG, Song C, Steinbeck K, Celermajer DS, and Freedman SB (2010) Increased tissue factor activity in monocytes from obese young adults. Clin Exp Pharmacol Physiol
http://www.ncbi.nlm.nih.gov/pubmed/20659134

Berthelsen LO, Kristensen AT, and Tranholm M (2010) Purified thromboplastin causes haemostatic abnormalities but not overt DIC in an experimental rabbit model. Thromb Res
http://www.ncbi.nlm.nih.gov/pubmed/20637496

Borawski J, Naumnik B, Dubowski M, and Mysliwiec M (2010) Full-length TFPI release by heparinoid sulodexide. Clin Appl Thromb Hemost 16:485-487.
http://www.ncbi.nlm.nih.gov/pubmed/20647229

Calabro P, Cirillo P, Limongelli G, Maddaloni V, Riegler L, et al. (2010) Tissue factor is induced by Resistin in human coronary artery endothelial cells by the NF-kB-dependent pathway. J Vasc Res 48:59-66.
http://www.ncbi.nlm.nih.gov/pubmed/20628259

Cheng Q, Tucker EI, Pine MS, Sisler I, Matafonov A, et al. (2010) A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo. Blood
http://www.ncbi.nlm.nih.gov/pubmed/20634381

Dang CN, Katakam LI, Smith PB, Cotten CM, Goldberg RN, Chandler N, Thornburg CD, and Bidegain M (2010) Recombinant activated factor VIIa treatment for refractory hemorrhage in infants. J Perinatol
http://www.ncbi.nlm.nih.gov/pubmed/20671714

Evola G, Novo G, Amoroso G, Guttilla D, Lo Coco L, Guagliardo M, Lupo A, Averna MR, Giambanco V, Miller V, and Novo S (2010) Modification of the lipidic and coagulative pattern in postmenopause women: Effect of hormone replacement therapy. Int Angiol 29:355-361.
http://www.ncbi.nlm.nih.gov/pubmed/20671654

Fadeeva OA, Panteleev MA, Karamzin SS, Balandina AN, Smirnov IV, and Ataullakhanov FI (2010) Thromboplastin immobilized on polystyrene surface exhibits kinetic characteristics close to those for the native protein and activates in vitro blood coagulation similarly to thromboplastin on fibroblasts. Biochemistry (Mosc ) 75:734-743.
http://www.ncbi.nlm.nih.gov/pubmed/20636265

Fang W, Zhang Q, Peng Y, Chen M, Lin X, Wu J, Cai C, Mei Y, and Jin H (2010) Resistin level is positively correlated with thrombotic complications in southern Chinese metabolic syndrome patients. J Endocrinol Invest
http://www.ncbi.nlm.nih.gov/pubmed/20671416

Franchini M and Lippi G (2010) Recombinant activated factor VII: Mechanisms of action and current indications. Semin Thromb Hemost 36:485-492.
http://www.ncbi.nlm.nih.gov/pubmed/20632246

Hindy-Francois C, Bachelot-Loza C, Le Bonniec B, Grelac F, Dizier B, Godier A, Emmerich J, Gaussem P, and Samama CM (2010) Recombinant activated factor VII does not reduce bleeding in rabbits treated with aspirin and clopidogrel. Thromb Haemost 104:
http://www.ncbi.nlm.nih.gov/pubmed/20664889

Huang ZJ, Luo Q, Yan JH, and Wang SY (2010) [Arginine-glycine-aspartic polypeptide mediated truncated tissue factor therapy for colorectal carcinoma.]. Zhonghua Wai Ke Za Zhi 48:619-623.
http://www.ncbi.nlm.nih.gov/pubmed/20646482

Key NS, De Paepe A, Malfait F, and Shovlin CL (2010) Vascular haemostasis. Haemophilia 16 Suppl 5:146-151.
http://www.ncbi.nlm.nih.gov/pubmed/20590874

Kim J, Min JK, Park JA, Doh HJ, Choi YS, Rho J, Kim YM, and Kwon YG (2010) Receptor activator of nuclear factor {kappa}B ligand is a novel inducer of tissue factor in macrophages. Circ Res
http://www.ncbi.nlm.nih.gov/pubmed/20671239

Lee H, Lee B, Kim Y, Paik N, and Rho H (2010) Characterization of transgenic pigs that express human decay accelerating factor and cell membrane-tethered human tissue factor pathway inhibitor. Reprod Domest Anim
http://www.ncbi.nlm.nih.gov/pubmed/20626677

Levi M, Lowenberg E, and Meijers JC (2010) Recombinant anticoagulant factors for adjunctive treatment of sepsis. Semin Thromb Hemost 36:550-557.
http://www.ncbi.nlm.nih.gov/pubmed/20632252

Li F, Wang CH, Wang JG, Thai T, Boysen G, Xu L, Turner AL, Wolberg AS, Mackman N, Maeda N, and Takahashi N (2010) Elevated tissue factor expression contributes to exacerbated diabetic nephropathy in mice lacking eNOS fed a high fat diet. J Thromb Haemost
http://www.ncbi.nlm.nih.gov/pubmed/20626618

Lin CC, Ezzelarab M, Shapiro R, Ekser B, Long C, et al. (2010) Recipient tissue factor expression is associated with consumptive coagulopathy in pig-to-primate kidney xenotransplantation. Am J Transplant 10:1556-1568.
http://www.ncbi.nlm.nih.gov/pubmed/20642682

Lund T, Hermansen SE, Andreasen TV, Olsen JO, Osterud B, Myrmel T, and Ytrehus K (2010) Shear stress regulates inflammatory and thrombogenic gene transcripts in cultured human endothelial progenitor cells. Thromb Haemost 104:
http://www.ncbi.nlm.nih.gov/pubmed/20664910

Macey MG, Wolf SI, and Lawson C (2010) Microparticle formation after exposure of blood to activated endothelium under flow. Cytometry A 77:761-768.
http://www.ncbi.nlm.nih.gov/pubmed/20653016

Macey MG, Enniks N, and Bevan S (2010) Flow cytometric analysis of microparticle phenotype and their role in thrombin generation. Cytometry B Clin Cytom
http://www.ncbi.nlm.nih.gov/pubmed/20632415

Miller MA, Kandala NB, Kumari M, Marmot MG, and Cappuccio FP (2010) Relationships between sleep duration and von Willebrand factor, factor VII, and fibrinogen. Whitehall II Study. Arterioscler Thromb Vasc Biol
http://www.ncbi.nlm.nih.gov/pubmed/20651279

Nadir Y, Brenner B, Fux L, Shafat I, Attias J, and Vlodavsky I (2010) Heparanase enhances factor Xa generation in the presence of tissue-factor and factor VIIa. Haematologica
http://www.ncbi.nlm.nih.gov/pubmed/20634491

Picchiassi E, Coata G, Centra M, Pennacchi L, Bini V, and Di Renzo GC (2010) Identification of universal mRNA markers for noninvasive prenatal screening of trisomies. Prenat Diagn 30:764-770.
http://www.ncbi.nlm.nih.gov/pubmed/20661890

Ruf W and Versteeg HH (2010) Tissue factor mutated at the allosteric Cys186-Cys209 disulfide bond is severely impaired in decrypted procoagulant activity. Blood 116:500-501.
http://www.ncbi.nlm.nih.gov/pubmed/20651086

Scultetus A, Arnaud F, Kaplan L, Shander A, Philbin N, Rice J, McCarron R, and Freilich D (2010) Hemoglobin-based oxygen carrier (HBOC-201) and escalating doses of recombinant factor VIIa (rFVIIa) as a novel pre-hospital resuscitation fluid in a swine model of severe uncontrolled hemorrhage. Artif Cells Blood Substit Immobil Biotechnol
http://www.ncbi.nlm.nih.gov/pubmed/20645681

Sovershaev MA, Egorina EM, Bogdanov VY, Seredkina N, Fallon JT, Valkov AY, Osterud B, and Hansen JB (2010) Bone morphogenetic protein-7 increases thrombogenicity of lipid-rich atherosclerotic plaques via activation of tissue factor. Thromb Res
http://www.ncbi.nlm.nih.gov/pubmed/20656331

Tripodi A, Chantarangkul V, van den Besselaar AM, Witteveen E, and Hubbard AR (2010) International collaborative study for the calibration of a proposed international standard for thromboplastin, human, plain. J Thromb Haemost
http://www.ncbi.nlm.nih.gov/pubmed/20626621

Wilson HM (2010) Macrophages heterogeneity in atherosclerosis - implications for therapy. J Cell Mol Med
http://www.ncbi.nlm.nih.gov/pubmed/20629993
__________________________________________________________
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.

DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________